Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22851655.
- Also identified by DOI 10.1093/eurheartj/ehs223.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transcatheter aortic valve implantation (TAVI) has been increasingly recognized as a curative treatment for severe aortic stenosis (AS). Despite important improvements in current device technology and implantation techniques, specific complications still remain and warrant consideration. Vascular complications and peri-procedural neurological events were the first concerns to emerge with this new technology. Recently, significant post procedural para-valvular leak has been shown to be more frequent after TAVI than after surgical aortic valve replacement (SAVR), and its potential association with worse long-term prognostic has raised concerns. In moving toward treatment of lower risk populations, structural integrity and long-term durability of heat valve prosthesis are becoming of central importance. Emerging technologies and newer generations of devices seem promising in dealing with these matters.
Medical subject headings
- Aortic Valve Stenosis
- Cardiac Catheterization
- Heart Valve Prosthesis
- Heart Valve Prosthesis Implantation